Advertisement

Behavior and Social Issues

, Volume 15, Issue 2, pp 222–231 | Cite as

Six-to-One Gets the Job Done: Comments on the Reviews

  • W. Joseph WyattEmail author
  • Donna M. Midkiff
Responses to Commentaries

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Antonuccio, D. O., Danton, W. G. & McClanahan, T. M. (2003). Psychology in the prescription era: Building a firewall between marketing and science. American Psychologist, 58, 1028–1043.  https://doi.org/10.1037/0003-066X.58.12.1028CrossRefGoogle Scholar
  2. Blumenthal. J. (2006). The treatment of behavior: Drugs or behavior analysis. Behavior and Social Issues, 15, 196–198.  https://doi.org/10.5210/bsi.v15i2.364CrossRefGoogle Scholar
  3. Delgado, P. & Moreno, F. (2000). Role of norepinephrine in depression. Journal of Clinical Psychiatry, 61, 5–11.PubMedPubMedCentralGoogle Scholar
  4. Hanson, M. (2006). Commentary on Wong, Wyatt and Midkiff. Behavior and Social Issues, 15, 178–180.  https://doi.org/10.5210/bsi.v15i2.371CrossRefGoogle Scholar
  5. Harshbarger, D. (2006). The evening news and the behavioral blues: Comments on Joseph Wyatt and Donna Midkiff’s Biological Psychiatry: A Practice in Search of a Science, and Stephen Wong’s Behavior Analysis of Psychotic Disorders: Scientific Dead End or Casualty of the Mental Health Political Economy? Behavior and Social Issues, 15, 199–201.  https://doi.org/10.5210/bsi.v15i2.392CrossRefGoogle Scholar
  6. Eli Lilly (1998 January). Prozac advertisement. People Magazine, p. 40.Google Scholar
  7. Forest Pharmaceuticals (2005). Frequently asked questions. New York: Forest Pharmaceuticals. Retrieved December 1, 2005 from https://doi.org/www.celexa.com/elexa/faq.aspx.
  8. Forest Pharmaceuticals (2005). How Lexapro (escitalopram) works. New York: Forest Pharmaceuticals. Retrieved December 1, 2005 from https://doi.org/www.lexapro.com/english/about_lexapro/how_works.aspx.
  9. GlaxoSmithKline (2001, October). Paxil advertisement. Newsweek, p. 61.Google Scholar
  10. Glenmullen, J. (2001). Prozac Backlash: Overcoming the dangers of Prozac, Zoloft, Paxil and other antidepressants with safe, effective alternatives. New York: Simon and Schuster.Google Scholar
  11. Healy, D. (2004). Let them eat Prozac: The unhealthy relationship between the pharmaceutical companies and depression. New York: New York University.Google Scholar
  12. Kirsch, I., Moore, T. J. & Scoboria, A. (2002). The emperor’s new drugs: An analysis of anti-depressant medication data submitted to the U. S. Food and Drug Administration. Prevention & Treatment, 5, Article 23. Retrieved July 26, 2004, from https://doi.org/http://journals.apa.org/prevention/volum5/toc-jul15-02.html.
  13. Kramer, P. (2002, July 7). Fighting the darkness in the mind. The New York Times, Section 4, p. 8.Google Scholar
  14. Kravitz, R. L., Epstein, R. M., Feldman, M.D., Franz, C. E., Azari, R., Wilks, M. S., Hinton, L. & Franks, P. (2005). Influence of patients’ requests for direct-to-consumer advertised antidepressants. Journal of the American Medical Association, 293, 1995–2002.  https://doi.org/10.1001/jama.293.16.1995CrossRefGoogle Scholar
  15. Lacasse, J. R. & Gomory, T. (2003). Is graduate social work education promoting a critical approach to mental health practice? Journal of Social Work Education, 39, 383–408.CrossRefGoogle Scholar
  16. Leiberman, J. A., Stroup, T. S., McEvoy, J., Swartz, M., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., Severe, J. & Hsiao, J. K. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353, 1209–1223.CrossRefGoogle Scholar
  17. Mitchell, C. G. (2006). Response to Wong, Wyatt and Midkiff. Behavior and Social Issues, 15, 181–184.  https://doi.org/10.5210/bsi.v15i2.368CrossRefGoogle Scholar
  18. Pfizer (2004 March). Zoloft advertisement. Burbank (California): NBC.Google Scholar
  19. Rakos, R. F. (2006). Applied behavior analysis: Niche therapy par excellance. Behavior and Social Issues, 15, 185–191.  https://doi.org/10.5210/bsi.v15i2.367CrossRefGoogle Scholar
  20. Salzinger, K. (2006). Behavior analysis in the real world. Behavior and Social Issues, 15, 192–195.  https://doi.org/10.5210/bsi.v15i2.366CrossRefGoogle Scholar
  21. Valenstein, E. S. (1998). Blaming the brain: The truth about drugs and mental health. New York: Free Press.Google Scholar
  22. Wakefield, J. C. (2006). Is behaviorism becoming a pseudo-science?: Power versus scientific rationality in the eclipse of token economies by biological psychiatry in the treatment of schizophrenia. Behavior and Social Issues, 15, 202–221.  https://doi.org/10.5210/bsi.v15i2.363CrossRefGoogle Scholar
  23. Wyatt, W. J., Lamal, P. A., Newman, B. & Hobbie, S. A. (1997). Treatment of behavior analysis in five leading introductory psychology textbooks. Monograph published by BALANCE, a Special Interest Group of the Association for Behavior Analysis International.Google Scholar

Copyright information

© W. Joseph Wyatt & Donna M. Midkiff 2006

Authors and Affiliations

  1. 1.Marshall UniversityUSA

Personalised recommendations